PROYECTO DE BIOMEDICINA CIMA S L has a total of 47 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia, Brazil and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are PROYECTO BIOMEDICINA CIMA SL, BEIJING NORTHLAND BIOTECH CO and THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 33 | |
#2 | Brazil | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 3 | |
#5 | Canada | 1 | |
#6 | Hungary | 1 | |
#7 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Foods and drinks | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Analysing materials | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Heterocyclic compounds | |
#9 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Prieto Valtuena Jesus | 8 |
#2 | Lasarte Sagastibelza Juan Jose | 6 |
#3 | Valtuena Jesus Prieto | 6 |
#4 | Sagastibelza Juan Jose Lasarte | 5 |
#5 | Orbe Lopategui Josune | 5 |
#6 | Prieto Valtuena Jesus Maria | 4 |
#7 | Ugarriza Pablo Sarobe | 4 |
#8 | Borras Cuesta Francisco | 4 |
#9 | Sarobe Ugarriza Pablo | 4 |
#10 | Cuesta Francisco Borras | 3 |
Publication | Filing date | Title |
---|---|---|
AU2013292076A1 | New antifibrinolytic compounds | |
US2015072361A1 | Lung cancer molecular markers | |
BR112012013868A2 | composition, fusion protein, polynucleotide, gene vector or construct, host cell, pharmaceutical composition, in vitro method and use of a composition. | |
EP2476440A1 | Therapeutic compositions for the treatment of hpv-induced diseases | |
AU2010258589A1 | 5'-methylthioadenosine neuroprotective properties | |
AU2010227419A1 | Methods and compositions for the treatment of cirrhosis and liver fibrosis | |
AU2009297243A1 | Porphobilinogen deaminase gene therapy | |
AU2005337776A1 | Use of TGF-Beta1 inhibitor peptides in the preparation of an immune response modulating agent | |
AU2005329287A1 | Use of 5'-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection |